share_log

康弘药业:关于2022年股票增值权激励计划第二个行权期行权条件达成的公告

Kanghong Pharmaceutical: Announcement on reaching the exercise conditions for the second exercise period of the 2022 Stock Value-added Rights Incentive Plan

SZSI ·  Oct 25

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.